| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.35 | 0.05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.6 | 0.05 |